Government Offers Ovarian Cancer Cell Line for License
Published Date: 6/16/2026
Notice
Summary
The National Cancer Institute is offering a special ovarian cancer cell line called A1847 for researchers to license and use. This cell line helps scientists study how ovarian cancer grows and find better treatments, especially for tough cases linked to BRCA1 gene problems. If you’re into cancer research, this is your chance to get a powerful tool starting now, with no big costs for licensing.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
A1847 Ovarian Cancer Cell Line Offered
The National Cancer Institute is offering the A1847 human ovarian carcinoma cell line for nonexclusive license (NIH Reference E-137-2023-0). The line is BRCA1-deficient, was derived from a 50-year-old female, and is karyotypically characterized with modal number 68 and 3 marker chromosomes; it is offered as a research material/tool for screening drug candidates, identifying therapeutic targets, and generating animal models for metastatic ovarian cancer.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12106 — Submission for OMB Review; 30-Day Comment Request; NIH Extramural Harassment Web Form (Office of the Director, Office of Extramural Research)
The NIH wants to keep their Extramural Harassment Web Form active so people working with NIH grants can safely report harassment. They’re asking the public to share thoughts by July 16, 2026, but no changes or costs are involved—just a smooth continuation. This helps keep NIH’s research community respectful and safe!
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
Previous / Next Documents
Previous: 2026-12068 — Boulder Canyon Project
The Western Area Power Administration is keeping the Boulder Canyon Project electric rates steady at $76.2 million for fiscal year 2027, starting October 1, 2026. This means no price hikes for customers in the Desert Southwest region. Public meetings and a comment period from June 16 to September 14, 2026, invite everyone to learn more and share their thoughts.
Next: 2026-12072 — Foreign-Trade Zone 44; Application for Subzone; Perlen Packaging LLC; Whippany, New Jersey
Perlen Packaging LLC in Whippany, New Jersey, wants to join Foreign-Trade Zone 44 as a special subzone. This means they can enjoy some trade benefits, but no production changes are planned yet. The public can share their thoughts by July 27, 2026, so don’t miss your chance to weigh in!